Free Trial

RAPT Therapeutics (RAPT) Earnings Date, Estimates & Call Transcripts

$3.55
-0.14 (-3.79%)
(As of 05:17 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(May. 9)
-$0.79 Missed By -$0.01
Consensus EPS
(May. 9)
-$0.78
Skip Charts & View Estimated and Actual Earnings Data

RAPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RAPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

RAPT Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)($0.82)($0.83)
Q2 20242($0.91)($0.81)($0.86)
Q3 20242($0.88)($0.79)($0.84)
Q4 20242($0.80)($0.78)($0.79)
FY 20248($3.43)($3.20)($3.32)

RAPT Earnings Date and Information

RAPT Therapeutics last posted its earnings results on May 9th, 2024. The reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.78) by $0.01. RAPT Therapeutics has generated ($3.07) earnings per share over the last year (($3.07) diluted earnings per share). Earnings for RAPT Therapeutics are expected to grow in the coming year, from ($2.93) to ($2.05) per share. RAPT Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.

RAPT Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2024
(Estimated)
------- 
5/9/2024Q1 2024($0.78)($0.79)($0.01)($0.79)--
3/7/2024Q4 2023($0.85)($0.80)+$0.05($0.80)--
11/13/2023Q3 2023($0.75)($0.82)($0.07)($0.82)--
8/11/2023Q2 2023($0.78)($0.66)+$0.12($0.66)--
5/11/2023Q1 2023($0.64)($0.76)($0.12)($0.76)--
3/14/2023Q4 2022($0.67)($0.64)+$0.03($0.64)--
11/10/2022Q3 2022($0.65)($0.63)+$0.02($0.63)--
8/11/2022Q2 2022($0.75)($0.62)+$0.13($0.62)$0.40 million$0.89 million
5/11/2022Q1 2022($0.66)($0.69)($0.03)($0.69)$0.40 million$0.64 million
3/10/2022Q4 2021($0.66)($0.61)+$0.05($0.61)$1.50 million$0.76 million
11/10/2021Q3 2021($0.62)($0.63)($0.01)($0.63)$1.45 million$0.97 million
8/11/2021Q2 2021($0.68)($0.63)+$0.05($0.63)$1.43 million$0.87 million
5/11/2021Q1 2021($0.60)($0.66)($0.06)($0.66)$1.70 million$1.22 million
3/11/2021Q4 2020($0.58)($0.52)+$0.06($0.52)$2.05 million$1.30 million
11/15/2020Q3 2020($0.56)($0.60)($0.04)($0.60)$2.50 million$1.53 million
8/13/2020Q2 2020($0.5770)($0.5090)+$0.0680($0.51)$2.50 million$1.28 million
5/14/2020Q1 2020($0.43)($0.56)($0.13)($0.56)$2.50 million$0.94 million
3/30/2020Q4 2019($0.74)($0.82)($0.08)($0.87)--
12/11/2019Q3 2019($6.15)($12.41)($6.26)($12.41)--

RAPT Therapeutics Earnings - Frequently Asked Questions

When is RAPT Therapeutics's earnings date?

RAPT Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on RAPT's earnings history.

Did RAPT Therapeutics beat their earnings estimates last quarter?

In the previous quarter, RAPT Therapeutics (NASDAQ:RAPT) missed the analysts' consensus estimate of ($0.78) by $0.01 with a reported earnings per share (EPS) of ($0.79). Learn more on analysts' earnings estimate vs. RAPT's actual earnings.

How much revenue does RAPT Therapeutics generate each year?

RAPT Therapeutics (NASDAQ:RAPT) has a recorded annual revenue of $1.53 million.

How much profit does RAPT Therapeutics generate each year?

RAPT Therapeutics (NASDAQ:RAPT) has a recorded net income of -$116.80 million. RAPT has generated -$3.07 earnings per share over the last four quarters.

What is RAPT Therapeutics's EPS forecast for next year?

RAPT Therapeutics's earnings are expected to grow from ($2.93) per share to ($2.05) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RAPT) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners